We are pleased to share a paper from our lab out in this week’s issue of @Nature, where we show that HT + ML can dramatically speed up the synbio DBTL cycles, profiling gene circuit design spaces at unprecedented scale: https://t.co/7FwDVN4259 (1/16)
Exciting breakthrough technology from the lab, now live in @CellCellPress ! Instead of cutting the genome where proteins bind (e.g., Cut&Tag), D&D-seq scars the DNA with a deaminase, allowing single cell genome mapping of TFs and chromatin remodellers!
The preprint from my work @MoKhalilLab and @DunlopLab at BU is out on bioRxiv! As new tools come online to engineer multicellularity, we asked: how does sticking cells together into larger groups affect their fitness and function?
Lovely study by the team, showing how TF specificity emerges from weak and multivalent interactions! (a property we've been obsessed with modeling, designing and engineering in cells 😍)
Characterizing AI-designed proteins requires quantitative biochemistry at massive scale. Enter Amplicon/Protein Bead Display (APB-Display), a fully in vitro platform that quantifies Kd's for >100,000 variants in <3 days (preprint link below!) @Stanford_ChEMH@czbiohub (1/n)
🚨 1/5 Check out the 2nd preprint from our lab on how IRES-mediated translation of synthetic circRNAs is employed in cells and in cell-free translation extracts, a highly collaborative effort with Immagina & the labs of Anders Lund and CK Chen.
In this project with Tyler Dao, Aviv Regev, Alex Shalek, and others (@shaleklab@broadinstitute@MIT@ragoninstitute), we combined genetics with molecular biology, computational protein modeling, and imaging to investigate T cell receptor signal branching. (2/4)
1/ Excited to share our new paper in Science: “Toward life with a 19-amino acid alphabet through generative artificial intelligence design.” @ColumbiaSysBio@ColumbiaBME@Columbia
https://t.co/ZT3Ygw9tiG 🦠🧬🛠️🖥️💥
Excited to share our work on ErbB receptors published today @CellCellPress! Using multicolor, photostable UCNPs, we perform long-term (>15 min) single-particle tracking of EGFR, HER2, and HER3, enabling direct visualization of dimerization in live cells. https://t.co/BZdJHyctl2
Finally out in @naturemethods 🎉 Our work with @ywan_wan's lab shows that signal alignments from direct RNA @nanopore sequencing can reveal structural heterogeneity in RNA. Huge implications for RNA therapeutics!
Read all about it here: https://t.co/ZRGNwA9Dg7
The size of new DNA sequences that can be integrated into the human genome is a foundational constraint for engineering and enhancing human cells. In a new collaborative study, we’ve now almost doubled the maximum size of DNA sequences that can be efficiently inserted into primary human cells.
https://t.co/9Dho2VDbEo
New preprint alert - 5 years in the making! Using high-throughput microfluidic enzyme kinetics, we profiled 190 clinical variants of SHP2, a phosphatase linked to developmental disorders & cancer (1/8)
https://t.co/wSO3Uv2gia
@Stanford_ChEMH, @czbiohub, @bioe_stanford
Finding new medicines is getting more and more expensive, and AI won't help much unless we can generate physiological data at scale.
In our new preprint, @GordianBio extends the progress of the functional genomics community to run pooled in vivo screens at scale, in a way that answers questions about physiology and therapeutic potential.
We show screens in mice and horses, fibrotic and degenerative disease, with a framework for physiological predictions validated in human ex vivo tissues.
Very proud of @v_sontake, @vkartha88, Neety and the rest of the team. Tweetorial follows:
Evolution navigated billions of challenges to get to us to where we are today. Directed evolution compresses this to 1D axis.
Imagine if you could sample 200 dimensions at once, with data to boot 📈
First @chorylab PACE preprint on our new system to tackle this: TurboPRANCE👇
Very happy to see this work from Fabian Rehm, Jason Chin, and team on the development of a high error-rate orthogonal DNA replication system in E. coli, thus supporting continuous hypermutation and evolution of target genes in vivo. The system is based on a protein-primed linear plasmid replication mechanism, which has become a reliable way of realizing the orthogonal replication concept through which hypermutation is durably targeted to an orthogonal plasmid while sparing the genome. Our original orthogonal DNA replication (OrthoRep) system in yeast, Rongzhen Tian's and Jason Chin's BacORep and EcORep systems in bacteria, and now this promising new system all repurpose protein-primed replication to achieve orthogonality. I look forward to seeing how these systems continue to be applied to gene and biomolecular evolution at scale! https://t.co/HYLmVPOftV